Actuate Therapeutics, Inc.
ACTU· Nasdaq
Actuate Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · +9.58%
- Market cap
- $20.89M
- 24.01M shares
- Filings
- 178
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $10,292,620 | reported | |
| FY 2024 | 2024-12-31 | $18,676,276 | reported | |
| FY 2023 | 2023-12-31 | $21,708,332 | reported |
Actuate Therapeutics, Inc. · CIK 1652935 · Engraved from SEC EDGAR
